Despite the absence of studies focusing on the m1A modification in MM, as previously mentioned, MALAT1 overexpression is correlated with worse prognosis, and the oncogenic role of MALAT1 in promoting MM tumorigenesis has been widely studied (35, 56, 107). This evidence concerns the gene MALAT1 and Miyoshi myopathy.